NERRE THERAPEUTICS HOLDINGS LIMITED
Company number 10753026
- Company Overview for NERRE THERAPEUTICS HOLDINGS LIMITED (10753026)
- Filing history for NERRE THERAPEUTICS HOLDINGS LIMITED (10753026)
- People for NERRE THERAPEUTICS HOLDINGS LIMITED (10753026)
- More for NERRE THERAPEUTICS HOLDINGS LIMITED (10753026)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
18 Oct 2017 | AP01 | Appointment of Dr Iain David Dukes as a director on 8 September 2017 | |
17 Oct 2017 | AP01 | Appointment of Dr Ena Prosser as a director on 8 September 2017 | |
17 Oct 2017 | AP01 | Appointment of Dr Geert Jan Mulder as a director on 8 September 2017 | |
17 Oct 2017 | AP01 | Appointment of Dr Saiyed Kaasim Mahmood as a director on 8 September 2017 | |
17 Oct 2017 | PSC07 | Cessation of Michael Keith Trower as a person with significant control on 8 September 2017 | |
17 Oct 2017 | TM01 | Termination of appointment of Michael Keith Trower as a director on 8 September 2017 | |
17 Oct 2017 | AP01 | Appointment of Dr Mary Kerr as a director on 8 September 2017 | |
11 Oct 2017 | SH01 |
Statement of capital following an allotment of shares on 8 September 2017
|
|
11 Oct 2017 | SH08 | Change of share class name or designation | |
09 Oct 2017 | MA | Memorandum and Articles of Association | |
09 Oct 2017 | RESOLUTIONS |
Resolutions
|
|
21 Sep 2017 | SH08 | Change of share class name or designation | |
20 Sep 2017 | RESOLUTIONS |
Resolutions
|
|
14 Sep 2017 | SH20 | Statement by Directors | |
14 Sep 2017 | SH19 |
Statement of capital on 14 September 2017
|
|
14 Sep 2017 | CAP-SS | Solvency Statement dated 14/09/17 | |
14 Sep 2017 | RESOLUTIONS |
Resolutions
|
|
08 Aug 2017 | AA01 | Current accounting period extended from 31 May 2018 to 30 June 2018 | |
03 May 2017 | NEWINC |
Incorporation
Statement of capital on 2017-05-03
|